These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 36082093)

  • 1. A case of matrix-producing carcinoma of the breast treated with preoperative chemotherapy.
    Kimura A; Yamada A; Shibata Y; Inoue S; Oshi M; Harada F; Kadokura T; Takeuchi H; Hasegawa N; Kakuta Y; Endo I; Chishima T
    Gland Surg; 2022 Aug; 11(8):1424-1430. PubMed ID: 36082093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A Case of Matrix-Producing Carcinoma of the Breast].
    Inoue Y; Joden F; Yabuki K; Sato N; Minagawa N; Katsuki T; Sato N; Nagata T; Shibao K; Matsuyama A; Aoki T; Hirata K
    J UOEH; 2017; 39(2):167-173. PubMed ID: 28626128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of an invasive ductal carcinoma in a contralateral composite nipple graft after an autologous breast reconstruction: a case report.
    Kimura M; Narui K; Shima H; Ikejima S; Muto M; Satake T; Tanabe M; Inayama Y; Adachi S; Yamada A; Shimada K; Sugae S; Ichikawa Y; Ishikawa T; Endo I
    Surg Case Rep; 2020 Aug; 6(1):203. PubMed ID: 32770432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A case report of matrix-producing carcinoma of the breast].
    Nitta K; Egawa C; Ishida T; Sato Y; Morimoto Y; Kusama H; Hashimoto T; Matsushita K; Kimura K; Katsura Y; Kagawa Y; Okishiro M; Takeno A; Sakisaka H; Nakahira S; Taniguchi H; Takeda Y; Kato T; Oku K; Goto T; Nagano T; Nakatsuka S; Tamura S; Takatsuka Y
    Gan To Kagaku Ryoho; 2014 Nov; 41(12):1936-8. PubMed ID: 25731381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HER2-Positive Metaplastic Breast Cancer with Resistance to Neoadjuvant Chemotherapy: Case Report.
    Tateishi K; Kiyoi M; Miyasaka M; Kawaji M; Nakanishi H; Furuta Y; Nishimatsu M; Takahashi Y; Nishikawa M; Nishimura Y
    Case Rep Oncol; 2023; 16(1):1482-1488. PubMed ID: 38028581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Case Report of Triple-Positive Micropapillary Carcinoma of the Male Breast.
    Shuja J; Ahmad I; Arshad S; Manzoor H; Kakar S; Ahmad K
    Breast Care (Basel); 2018 Jul; 13(3):192-194. PubMed ID: 30069180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maximizing the Clinical Benefit of Anthracyclines in Addition to Taxanes in the Adjuvant Treatment of Early Breast Cancer.
    Curigliano G; Criscitiello C
    J Clin Oncol; 2017 Aug; 35(23):2600-2603. PubMed ID: 28661760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current and Emerging Therapies for HER2-Positive Women With Metastatic Breast Cancer.
    Porter K; Rosenzweig MQ
    J Adv Pract Oncol; 2017 Mar; 8(2):164-168. PubMed ID: 29900024
    [No Abstract]   [Full Text] [Related]  

  • 9. [Synchronous and Unilateral Breast Cancers(Invasive Lobular Carcinoma and Non-Invasive Ductal Carcinoma) - A Case Report].
    Sakurai K; Fujisaki S; Kubota H; Hara Y; Suzuki S; Adachi K; Tomita R; Enomoto K; Hirano T
    Gan To Kagaku Ryoho; 2018 Jan; 45(1):73-75. PubMed ID: 29362312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A case of giant advanced ulcerative breast cancer managed with epirubicin and cyclophosphamide followed by weekly paclitaxel].
    Moriya T; Fukatsu K; Ueda S; Iwaya K; Osaki A; Yamamoto J
    Gan To Kagaku Ryoho; 2010 May; 37(5):907-10. PubMed ID: 20495326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Postmastectomy Radiotherapy in Locally Advanced Breast Cancer After Pathological Complete Response to Neoadjuvant Chemotherapy.
    Flores-Balcázar CH; Castro-Alonso FJ; Hernández-Barragán TP; Delgado-de la Mora J; Daidone A; Trejo-Durán GE
    Oncology (Williston Park); 2021 Mar; 35(3):139-143. PubMed ID: 33818049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Two cases of recurrent breast cancer with regional lymph node metastases showing a complete response to trastuzumab and paclitaxel treatment].
    Ohsako T; Inoue K; Nagamoto N; Yoshida Y; Nakahara O
    Gan To Kagaku Ryoho; 2006 Sep; 33(9):1301-3. PubMed ID: 16969029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two cases of breast cancer with cartilaginous and osseous metaplasia.
    Ninomiya J; Oyama T; Horiguchi J; Koibuchi Y; Yoshida T; Iijima K; Yoshida M; Takata D; Iino Y; Morishita Y
    Breast Cancer; 2005; 12(1):52-6. PubMed ID: 15657524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tailored preoperative treatment of locally advanced triple negative (hormone receptor negative and HER2 negative) breast cancer with epirubicin, cisplatin, and infusional fluorouracil followed by weekly paclitaxel.
    Torrisi R; Balduzzi A; Ghisini R; Rocca A; Bottiglieri L; Giovanardi F; Veronesi P; Luini A; Orlando L; Viale G; Goldhirsch A; Colleoni M
    Cancer Chemother Pharmacol; 2008 Sep; 62(4):667-72. PubMed ID: 18064460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A study on clinico-pathological assessment of response to neoadjuvant chemotherapy in breast carcinoma.
    Mohapatra M; Sarma YS
    J Cancer Res Ther; 2020; 16(6):1419-1425. PubMed ID: 33342807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HER2 changes to positive after neoadjuvant chemotherapy in breast cancer: A case report and literature review.
    Wang L; Jiang Q; He MY; Shen P
    World J Clin Cases; 2022 Jan; 10(1):260-267. PubMed ID: 35071526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Long-Term Survival of a Patient with Triple-Negative Breast Cancer with Hormone Receptor Status Conversion between Primary and Metastatic Tumors].
    Hayashi K; Harao M; Ogihara K; Sasaki Y; Nishida S; Shiba S; Sakuragi M; Kitayama J; Sata N
    Gan To Kagaku Ryoho; 2022 Jun; 49(6):697-699. PubMed ID: 35799399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A Case of HER2-Positive Breast Cancer Treated with Nipple-Sparing Mastectomywith Immediate Reconstruction Using a Tissue Expander after Nab-Paclitaxel Combined with Chemotherapy].
    Nonomura A; Aomatsu N; Tei S; Haraoka G; Tsujio G; Yamakoshi Y; Wang E; Nagashima D; Hirakawa T; Iwauchi T; Nishii T; Morimoto J; Nakazawa K; Uchima Y; Takeuchi K
    Gan To Kagaku Ryoho; 2016 Nov; 43(12):2056-2058. PubMed ID: 28133220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current strategy for triple-negative breast cancer: appropriate combination of surgery, radiation, and chemotherapy.
    Yagata H; Kajiura Y; Yamauchi H
    Breast Cancer; 2011 Jul; 18(3):165-73. PubMed ID: 21290263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Case of Rare Matrix-producing Triple-negative Breast Carcinoma for Which Drug Response in a Patient-derived Orthotopic Xenograft Mouse Model Was Correlated With Patient Response.
    Nomura T; Kurebayashi J; Moriya T; Saito W; Murata T; Yamamoto J; Hozumi C; Hoffman RM
    Anticancer Res; 2021 Dec; 41(12):6191-6197. PubMed ID: 34848473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.